Cargando…

Hypertension in a multi‐ethnic Asian population of Singapore

The prevalence of hypertension varies by country and region, but it remains a leading yet modifiable risk factor of cardiovascular disease. There are many factors that contribute to the burden of hypertension in Asia, a region with diverse ethnicity. It has been shown that sociodemographic variabili...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chan, Gek Cher, Teo, Boon Wee, Tay, Jam Chin, Chen, Chen‐Huan, Cheng, Hao‐Min, Wang, Tzung‐Dau, Turana, Yuda, Kario, Kazuomi, Chia, Yook‐Chin, Tsoi, Kelvin, Sogunuru, Guru Prasad, Nailes, Jennifer
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2020
Materias:	Hypertension and Clinical Outcomes
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8029544/ https://www.ncbi.nlm.nih.gov/pubmed/33340436 http://dx.doi.org/10.1111/jch.14140

Ejemplares similares

Hypertension and erectile dysfunction: The role of endovascular therapy in Asia
por: Wang, Tzung‐Dau, et al.
Publicado: (2020)

Hypertension and chronic kidney disease in Asian populations
por: Teo, Boon Wee, et al.
Publicado: (2021)

Characteristics of hypertension in obstructive sleep apnea: An Asian experience
por: Hoshide, Satoshi, et al.
Publicado: (2021)

Hypertension and stroke in Asia: A comprehensive review from HOPE Asia
por: Turana, Yuda, et al.
Publicado: (2020)

Disaster hypertension and cardiovascular events in disaster and COVID‐19 pandemic
por: Narita, Keisuke, et al.
Publicado: (2021)

Mental health problems and hypertension in the elderly: Review from the HOPE Asia Network
por: Turana, Yuda, et al.
Publicado: (2020)

Applications of artificial intelligence for hypertension management
por: Tsoi, Kelvin, et al.
Publicado: (2021)

Assessment of preferred methods to measure insulin resistance in Asian patients with hypertension
por: Minh, Huynh Van, et al.
Publicado: (2021)

Long sleep duration and cardiovascular disease: Associations with arterial stiffness and blood pressure variability
por: Matsubayashi, Hideaki, et al.
Publicado: (2020)

Dietary intervention for the management of hypertension in Asia
por: Chang, Hao‐Chih, et al.
Publicado: (2020)

Angiotensin receptor neprilysin inhibitor as a novel antihypertensive drug: Evidence from Asia and around the globe
por: Lin, Donna S.‐H., et al.
Publicado: (2020)

The feasibility of polypill for cardiovascular disease prevention in Asian Population
por: Sukonthasarn, Apichard, et al.
Publicado: (2020)

Guidance on ambulatory blood pressure monitoring: A statement from the HOPE Asia Network
por: Kario, Kazuomi, et al.
Publicado: (2020)

Non‐pharmacological management of hypertension
por: Verma, Narsingh, et al.
Publicado: (2021)

Comparison of guidelines for the management of hypertension: Similarities and differences between international and Asian countries; perspectives from HOPE‐Asia Network
por: Chia, Yook‐Chin, et al.
Publicado: (2021)

Current status of adherence interventions in hypertension management in Asian countries: A report from the HOPE Asia Network
por: Shin, Jinho, et al.
Publicado: (2020)

Telemedicine in the management of hypertension: Evolving technological platforms for blood pressure telemonitoring
por: Wang, Ji‐Guang, et al.
Publicado: (2021)

Regional differences in office and self‐measured home heart rates in Asian hypertensive patients: AsiaBP@Home study
por: Tomitani, Naoko, et al.
Publicado: (2021)

Standardized home blood pressure monitoring: Rationale behind the 722 protocol
por: Lin, Hung‐Ju, et al.
Publicado: (2022)

The HOPE Asia network 2022 up‐date consensus statement on morning hypertension management
por: Kario, Kazuomi, et al.
Publicado: (2022)

Cardiovascular risk assessment tools in Asia
por: Zhang, Yuqing, et al.
Publicado: (2022)

Seven‐action approaches for the management of hypertension in Asia – The HOPE Asia network
por: Kario, Kazuomi, et al.
Publicado: (2022)

Targets and management of hypertension in heart failure: focusing on the stages of heart failure
por: Miao, Huanhuan, et al.
Publicado: (2022)

COVID‐19 and hypertension—evidence and practical management: Guidance from the HOPE Asia Network
por: Kario, Kazuomi, et al.
Publicado: (2020)

Clinical significance of nocturnal home blood pressure monitoring and nocturnal hypertension in Asia
por: Fujiwara, Takeshi, et al.
Publicado: (2021)

Insights on home blood pressure monitoring in Asia: Expert perspectives from 10 countries/regions
por: Wang, Ji‐Guang, et al.
Publicado: (2020)

The role of renal nerve stimulation in percutaneous renal denervation for hypertension: A mini‐review
por: Huang, Hui‐Chun, et al.
Publicado: (2022)

Role of α1‐blockers in the current management of hypertension
por: Li, Hua, et al.
Publicado: (2022)

Characteristics and control of the 24‐hour ambulatory blood pressure in patients with metabolic syndrome
por: Huang, Jian‐Feng, et al.
Publicado: (2021)

Sleep and nocturnal hypertension: Genes, environment, and individual profiles
por: Kario, Kazuomi
Publicado: (2022)

Office blood pressure measurement: A comprehensive review
por: Siddique, Saulat, et al.
Publicado: (2021)

Hypertensive emergencies in Asia: A brief review
por: Kotruchin, Praew, et al.
Publicado: (2022)

Hypertension and blood pressure variability management practices among physicians in Singapore
por: Setia, Sajita, et al.
Publicado: (2017)

Neurodegenerative diseases and blood pressure variability: A comprehensive review from HOPE Asia
por: Turana, Yuda, et al.
Publicado: (2022)

Ambulatory and home blood pressure monitoring: gaps between clinical guidelines and clinical practice in Singapore
por: Setia, Sajita, et al.
Publicado: (2017)

Isolated systolic hypertension in Asia
por: Tsai, Tsung‐Ying, et al.
Publicado: (2020)

Who should be screened for primary aldosteronism? A comprehensive review of current evidence
por: Huang, Wei‐Chieh, et al.
Publicado: (2022)

Current realities of home blood pressure monitoring from physicians’ perspectives: results from Asia HBPM survey 2020
por: Wang, Tzung-Dau, et al.
Publicado: (2023)

The combination of amlodipine/valsartan 5/160 mg produces less peripheral oedema than amlodipine 10 mg in hypertensive patients not adequately controlled with amlodipine 5 mg
por: Schrader, J, et al.
Publicado: (2009)

Endothelial Dysfunction in Diabetes: The role of reparatory mechanisms
por: Avogaro, Angelo, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_nbf4iguruu49ai7jv986cff8fh